Latest Asx News

Pengana International Equities has raised its fully franked quarterly dividend to 1.4 cents per share, reflecting confidence in its earnings. Meanwhile, the company’s Independent Board Committee continues to evaluate strategic options, promising an update by February’s end.

OMG Group Limited has reported its first positive operating cashflow quarter, driven by a 63% year-on-year sales increase and expansion into premium Japanese matcha wholesale. This milestone signals a turning point in the company’s growth trajectory.

Westgold Resources has reported a record-breaking second quarter for FY26, with gold production surging 33% and underlying cash build doubling to $365 million, while maintaining a debt-free balance sheet.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

St George Mining has extended its strategic alliance with US rare earths processor REalloys to finalise potential offtake agreements for high-grade rare earths from the Araxá Project in Brazil. This move aligns with US efforts to build independent rare earth supply chains critical for defence and green technologies.

Green & Gold Minerals reports outstanding high-grade gold drill results from Mt Wandoo and Little Wandoo, accelerating its development plans and expanding resource potential.

White Cliff Minerals has revealed promising deep drilling results at its Danvers Copper Deposit in Nunavut, Canada, extending known copper mineralisation beyond previous limits and identifying new near-surface zones.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Aurelia Metals reports a strong December quarter with production ramp-ups ahead of schedule at Federation Mine and robust progress across its Peak and Great Cobar projects, underpinning solid cash flow and a healthy balance sheet.

Aurelia Metals has delivered robust metal production and cash flow in Q2 FY26, reaffirming its full-year guidance while advancing key growth projects on schedule.